InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

20 October 2025

Name:

LIVING CELL TECHNOLOGIES LIMITED (LCT)
(This company subsequently changed its name to ALGORAE PHARMACEUTICALS LIMITED. You should refer to that name for Status.)

ISIN:

AU000000LCT6

Date of Listing:

01 September 2004

Subsequent Names:

Company Name	Start Date	End Date
ALGORAE PHARMACEUTICALS LIMITED	11/09/2023

Stock Exchange Status: (updated daily)

This company subsequently changed its name to ALGORAE PHARMACEUTICALS LIMITED. You should refer to that name for Stock Exchange Status.

Legal Status: (updated monthly)

ACN: 104 028 042ABN: 14 104 028 042
Registration Date: 17 March 2003

This company subsequently changed its name to ALGORAE PHARMACEUTICALS LIMITED. You should refer to that name for Legal Status.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

This company subsequently changed its name and is now ALGORAE PHARMACEUTICALS LIMITED. You should refer to that name for Capital Gains Tax Status.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

LIVING CELL TECHNOLOGIES LIMITED(LCT)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
ALGORAE PHARMACEUTICALS LIMITED	11/09/2023
LIVING CELL TECHNOLOGIES LIMITED		11/09/2023

Shareholder links

Our website ranking of LCT:

(5 out of 5)

COMPANY WEBSITE:

LCT website

LCT email

LCT investorRelations

LCT announcements

LCT annualreports

LCT directors

REGISTRY:

Level 5, 126 Philip Street Sydney NSW 2000 GPO Box 5193 Sydney NSW 2001

Tel : 1300 288 664 or +61 2 9698 5414
Fax : +61 2 8583 3040
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000LCT6

Address: Level 23, Rialto South Tower, 525 Collins Street, Melbourne VIC 3000
Tel: 1300 134 875 Fax: (02) 9233 4497

Date first listed: 01/09/2004
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Implants healthy cells to replace or repair damaged organs without the use of toxic drugs

News & Events

Expand this box to read and print

name changed to Algorae Pharmaceuticals Limited	11/09/2023
The suspension of trading in the securities of Living Cell Technologies Limited will be lifted immediately, following release of an announcement regarding a capital raising.	30/11/2016
Living Cell Technologies Limited has completed the placement of 74,117,647 shares at $0.085 to institutional and professional investors, raising $6.3m. The funds will be used for working capital to continue research and development, including completing the Phase IIb clinical trial of NTCELL for Parkinson's disease and treating the placebo patients at the most effective dose.	30/11/2016
The securities of Living Cell Technologies Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising.	28/11/2016
shares reinstated to quotation	30/07/2009
shares suspended from quotation pending an announcement	29/07/2009
shares reinstated to quotation	30/10/2007
shares suspended from quotation pending an announcement	29/10/2007
delisted from the Newcastle Stock Exchange today as the company had successfully applied to list its securities on ASX	01/09/2004

OFX Transferring Money Internationally to Free

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
08/09/2022	Robert Willcocks	500,000	$0.013	$6,500.00
06/06/2022	Carolyn Sue	1,000,000	$0.007	$7,000.00
03/06/2022	Robert Willcocks	1,000,000	$0.007	$7,000.00
06/11/2018	Robert Elliott	210,000	$0.046	$9,660.00
04/09/2018	Robert Elliott	123,000	$0.029	$3,567.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Belinda Di Bartolo	COO	13/12/2021
John Cowan	CFO	20/10/2008
Laurie Hunter	Independent Director	25/08/2006
Bradley Latham	Non Exec Director	03/07/2023
David Hainsworth	Director	31/10/2022
Bradley Dilkes	Director	31/10/2022
Madhukar Bhalla	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.